Related references
Note: Only part of the references are listed.Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
Rajya L. Gurung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Micro-RNAs in the aqueous humour of patients with diabetic macular oedema
Heeyoon Cho et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495
Katrin Spengler et al.
BIOCHEMICAL JOURNAL (2020)
Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment
Rajya L. Gurung et al.
JOURNAL OF DIABETES RESEARCH (2020)
Treatment of Diabetic Macular Edema
Eric J. Kim et al.
CURRENT DIABETES REPORTS (2019)
Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients
Eman A. Toraih et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Dual Roles of the AMP-Activated Protein Kinase Pathway in Angiogenesis
Yuanjun Li et al.
CELLS (2019)
Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
Moon Young Choi et al.
PLOS ONE (2019)
The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor
Elizabeth A. Coe et al.
PLOS GENETICS (2019)
VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema
Mehmet Tetikoglu et al.
INTERNATIONAL OPHTHALMOLOGY (2018)
Diabetic macular oedema: under-represented in the genetic analysis of diabetic retinopathy
Suzanne Broadgate et al.
ACTA OPHTHALMOLOGICA (2018)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Vandetanib (ZD6474) induces antiangiogenesis through mTOR-HIF-I alpha VEGF signaling axis in breast cancer cells
Ling Li et al.
ONCOTARGETS AND THERAPY (2018)
RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS
Thomas A. Ciulla et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer
Biplab Dasgupta et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Regulation and function of AMPK in physiology and diseases
Sang-Min Jeon
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adenosine Monophosphate-Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation
Sukriti Krishan et al.
MOLECULAR PHARMACOLOGY (2015)
Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes
Sherien F. El-Shazly et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
Supriya S. Dabir et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2014)
SLCO3A1, a Novel Crohn's Disease-Associated Gene, Regulates NF-κB Activity and Associates with Intestinal Perforation
Shu-Chen Wei et al.
PLOS ONE (2014)
Diabetic macular edema: new concepts in patho-physiology and treatment
Xinyuan Zhang et al.
CELL AND BIOSCIENCE (2014)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Foveal Cystoid Spaces Are Associated with Enlarged Foveal Avascular Zone and Microaneurysms in Diabetic Macular Edema
Tomoaki Murakami et al.
OPHTHALMOLOGY (2011)
Managing diabetic macular edema: The leading cause of diabetes blindness
Pedro Romero-Aroca
WORLD JOURNAL OF DIABETES (2011)
Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells -: Evidence for an AMPK→Rac1→Akt→Endothelial nitric-oxide synthase pathway
Yehoshua C. Levine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Overview of epidemiologic studies of diabetic retinopathy
Barbara Eden Kobrin Klein
OPHTHALMIC EPIDEMIOLOGY (2007)
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
RB Caldwelll et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAPI fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q2)
D Bodmer et al.
GENES CHROMOSOMES & CANCER (2003)
Share Paper
